BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31473612)

  • 1. The James Lind Alliance process approach: scoping review.
    Nygaard A; Halvorsrud L; Linnerud S; Grov EK; Bergland A
    BMJ Open; 2019 Aug; 9(8):e027473. PubMed ID: 31473612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the challenge of health research priority setting in partnership: reflections on the methodology used by the James Lind Alliance Pressure Ulcer Priority Setting Partnership.
    Madden M; Morley R
    Res Involv Engagem; 2016; 2():12. PubMed ID: 29062513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapting the James Lind Alliance priority setting process to better support patient participation: an example from cystic fibrosis.
    Rowbotham NJ; Smith SJ; Elliott ZC; Leighton PA; Rayner OC; Morley R; Smyth AR
    Res Involv Engagem; 2019; 5():24. PubMed ID: 31452934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research priorities in children requiring elective surgery for conditions affecting the lower limbs: a James Lind Alliance Priority Setting Partnership.
    Vella-Baldacchino M; Perry DC; Roposch A; Nicolaou N; Cooke S; Ellis P; Theologis T
    BMJ Open; 2019 Dec; 9(12):e033233. PubMed ID: 31892663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposed methodology for uncertainty extraction and verification in priority setting partnerships with the James Lind Alliance: an example from the Common Conditions Affecting the Hand and Wrist Priority Setting Partnership.
    Grindlay DJC; Davis TRC; Kennedy D; Larson D; Furniss D; Cowan K; Giddins G; Jain A; Trickett RW; Karantana A
    BMC Med Res Methodol; 2022 Nov; 22(1):292. PubMed ID: 36357847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership.
    Hailey L; Bundy C; Burstow H; Chandler D; Cowper R; Helliwell P; Joannes L; Kelly A; Kennedy B; Kinsella S; McAteer H; Mukherjee S; Packham J; Wise E; Young H; Coates LC
    Rheumatology (Oxford); 2023 Aug; 62(8):2716-2723. PubMed ID: 36453848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership - the PRioRiTy (Prioritising Recruitment in Randomised Trials) study.
    Healy P; Galvin S; Williamson PR; Treweek S; Whiting C; Maeso B; Bray C; Brocklehurst P; Moloney MC; Douiri A; Gamble C; Gardner HR; Mitchell D; Stewart D; Jordan J; O'Donnell M; Clarke M; Pavitt SH; Guegan EW; Blatch-Jones A; Smith V; Reay H; Devane D
    Trials; 2018 Mar; 19(1):147. PubMed ID: 29490702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A patient-clinician James Lind Alliance partnership to identify research priorities for hyperemesis gravidarum.
    Dean CR; Bierma H; Clarke R; Cleary B; Ellis P; Gadsby R; Gauw N; Lodge K; MacGibbon K; McBride M; Munro D; Nelson-Piercy C; O'Hara M; Penny H; Shorter K; Spijker R; Trovik J; Watford E; Painter RC
    BMJ Open; 2021 Jan; 11(1):e041254. PubMed ID: 33452191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dementia priority setting partnership with the James Lind Alliance: using patient and public involvement and the evidence base to inform the research agenda.
    Kelly S; Lafortune L; Hart N; Cowan K; Fenton M; Brayne C;
    Age Ageing; 2015 Nov; 44(6):985-93. PubMed ID: 26504119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research priorities in foot and ankle conditions: results of a UK priority setting partnership with the James Lind Alliance.
    Mangwani J; Hau M; Thomson L
    BMJ Open; 2023 May; 13(5):e070641. PubMed ID: 37192795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What happens after James Lind Alliance Priority Setting Partnerships? A qualitative study of contexts, processes and impacts.
    Staley K; Crowe S; Crocker JC; Madden M; Greenhalgh T
    Res Involv Engagem; 2020; 6():41. PubMed ID: 32670611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients', clinicians' and the research communities' priorities for treatment research: there is an important mismatch.
    Crowe S; Fenton M; Hall M; Cowan K; Chalmers I
    Res Involv Engagem; 2015; 1():2. PubMed ID: 29062491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. James Lind Alliance Priority Setting Partnership for Degenerative Cervical Myelopathy [AO Spine RECODE-DCM]: An Overview of the Methodology Used to Process and Short-List Research Uncertainties.
    Tetreault L; Mowforth O; Khan DZ; Gronlund T; Garwood P; Hazenbiller O; Harrop JS; Aarabi B; Rahimi-Movaghar V; Kurpad SN; Guest JD; Wilson JR; Kwon BK; Fehlings MG; Davies BM; Kotter MRN;
    Global Spine J; 2022 Feb; 12(1_suppl):19S-27S. PubMed ID: 35174731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research priorities for liver glycogen storage disease: An international priority setting partnership with the James Lind Alliance.
    Peeks F; Boonstra WF; de Baere L; Carøe C; Casswall T; Cohen D; Cowan K; Ferrecchia I; Ferriani A; Gimbert C; Landgren M; Maldonado NL; McMillan J; Nemeth A; Seidita N; Stachelhaus-Theimer U; Weinstein DA; Derks TGJ
    J Inherit Metab Dis; 2020 Mar; 43(2):279-289. PubMed ID: 31587328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying research priorities in cardiac surgery: a report from the James Lind Alliance Priority Setting Partnership in adult heart surgery.
    Lai FY; Abbasciano RG; Tabberer B; Kumar T; Murphy GJ;
    BMJ Open; 2020 Sep; 10(9):e038001. PubMed ID: 32883735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research priorities in pernicious anaemia: James Lind Alliance Priority Setting Partnership.
    Staley K; Ahmadi KR; Carter K; Cowan K; Seage H; Visser P; Ward N; Hooper M
    BMJ Open; 2022 Aug; 12(8):e065166. PubMed ID: 36002205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing the Top 10 Research Priorities for Adolescent and Young Adult (AYA) Cancer in Canada: A Protocol for a James Lind Alliance Priority Setting Partnership.
    Tutelman PR; Thurston C; Rader T; Henry B; Ranger T; Abdelaal M; Blue M; Buckland TW; Del Gobbo S; Dobson L; Gallant E; Heykoop C; Jansen M; Larsen L; Maseja N; Oberoi S; Ramasamy V; Smith M; Taylor E; Wendowsky N; Beattie S; Bender J; Birnie KA; Garland SN; Jibb L; Noel M; Schulte FSM
    Curr Oncol; 2024 May; 31(5):2874-2880. PubMed ID: 38785500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study.
    Brunsdon D; Biesty L; Brocklehurst P; Brueton V; Devane D; Elliott J; Galvin S; Gamble C; Gardner H; Healy P; Hood K; Jordan J; Lanz D; Maeso B; Roberts A; Skene I; Soulsby I; Stewart D; Torgerson D; Treweek S; Whiting C; Wren S; Worrall A; Gillies K
    Trials; 2019 Oct; 20(1):593. PubMed ID: 31615577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setting research priorities for Type 1 diabetes.
    Gadsby R; Snow R; Daly AC; Crowe S; Matyka K; Hall B; Petrie J
    Diabet Med; 2012 Oct; 29(10):1321-6. PubMed ID: 22823450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What matters to you? Engaging with children in the James Lind Alliance Children's Cancer Priority Setting Partnership.
    Aldiss S; Hart-Spencer P; Langton L; Malik S; McEvoy K; Morgan JE; Reed-Berendt R; Hollis R; Phillips B; Gibson F;
    Res Involv Engagem; 2023 Nov; 9(1):110. PubMed ID: 38037183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.